25 November 2015 | News | By BioSpectrum Bureau
Major pharma companies to launch Squarekids subcutaneous injection syringe
Japanese pharma giants Daiichi Sankyo Co. Ltd., Japan Vaccine Co. Ltd and Sanofi K.K. have announced that they will launch 'Squarekids subcutaneous injection syringe', a tetravalent combination vaccine (DPT-IPV) for the prevention of diphtheria, pertussis, tetanus and poliomyelitis (polio) on December 9, 2015.
Squarekids is a product manufactured by Kitasato Daiichi Sankyo Vaccine Co. Ltd., a Group company in Japan of Daiichi Sankyo. This product is a combination vaccine containing DPT vaccine of Kitasato Daiichi Sankyo Vaccine and inactivated polio vaccine (Salk vaccine) of Sanofi filled in prefilled syringes, which is the first tetravalent DTP-IPV combination vaccine in Japan that contains Salk inactivated polio vaccine.